Phase II calm extension study: Coxsackievirus A21 delivered intratumorally to patients with advanced melanoma induces immune-cell infiltration in the tumor microenvironment. (Q45907294)
Jump to navigation
Jump to search
scientific article published on 4 November 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase II calm extension study: Coxsackievirus A21 delivered intratumorally to patients with advanced melanoma induces immune-cell infiltration in the tumor microenvironment. |
scientific article published on 4 November 2015 |
Statements
1 reference
Phase II calm extension study: Coxsackievirus A21 delivered intratumorally to patients with advanced melanoma induces immune-cell infiltration in the tumor microenvironment. (English)
1 reference
Bernard Fox
1 reference
Robert HI Andtbacka
1 reference
Brendan D Curti
1 reference
Sigrun Hallmeyer
1 reference
Zipei Feng
1 reference
Christopher Paustian
1 reference
Carlo Bifulco
1 reference
Mark Grose
1 reference
Darren Shafren
1 reference
4 November 2015
1 reference
3
1 reference
Suppl 2
1 reference
P343-P343
1 reference
Identifiers
1 reference